methodology described, it would be helpful to have answers to the following questions: (i) How many patients (according to treatment group) received midazolam? (ii) What doses (range and mean) were administered to those patients receiving midazolam?
1 Radtke FM, Franck M, Lendner J, Kruger S, Wernecke KD, Spies CD.
Monitoring depth of anaesthesia in a randomized trial decreases the rate of postoperative delirium but not postoperative cognitive dysfunction. Perioperative non-invasive estimation of left ventricular elastance (Ees) is no longer a challenge; it is a reality Editor-We read with great interest the recent article 'Minimally invasive intraoperative estimation of left-ventricular end-systolic elastance with phenylephrine as loading intervention' by Boly and colleagues 1 published in BJA. We appreciate the message that the anaesthetist should not rely only on arterial pressure and heart rate when managing haemodynamic instability, but needs to think in terms of myocardial performance. However, in our opinion, the study raises several concerns. We are unsure why an interventional or invasive procedure such as administering phenylephrine or clamping the inferior vena cava (IVC) is necessary in high-risk patients since several techniques are available to determine Ees noninvasively. 2 We have, in the past, measured Ees by changing the loading conditions pharmacologically, 3 but have moved to a completely non-invasive method. 4 Moreover, measuring
Ees alone, although important, does not provide the full potential of such pathophysiological approach. In fact, measuring Ees in combination with arterial elastance (Ea) offers the opportunity to calculate ventriculo-arterial (VA) coupling, which is a measure of cardiovascular energetic efficiency.
5
In our experience, these measurements have changed our practice of administering drugs active on the heart and vessels both in the intensive care unit and theatre, introducing a more physiological way of targeting the haemodynamic derangements. We agree with Dr Boly and colleagues that going back to pathophysiology helps to better understand haemodynamics in altered cardiovascular states.
Therefore, as non-invasive single-beat measurement of Ees, Ea, and VA coupling is already feasible and safe in the critically ill setting, we advocate that further efforts should concentrate on implementing ways to continuously and non-invasively determine these entities in a real-time fashion. 
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